Author:
Boccazzi A,Rizzo M,Caccamo M L,Assael B M
Abstract
The concentrations of ceftazidime in serum were studied in 16 preterm and term neonates to whom a single dose of 50 mg/kg had been administered intramuscularly or intravenously. After intramuscular injection, concentrations of ceftazidime in serum were comparable to those obtained with the intravenous dose, although they were more variable. Peak serum levels ranging from 50 to 102 micrograms/ml were reached 30 to 60 min after intramuscular injection. The concentrations declined monoexponentially after the peak, with a mean half-life of 3.8 +/- 1.1 h. Concentrations of ceftazidime in serum declined biexponentially after intravenous injection, with a terminal half-life of 4.7 +/- 1.5 h.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference7 articles.
1. Brumftt W. and J. M. T. HaN_n-Miller. 1981. The susceptibility of nosocomial pathogens to ceftazidime. J. Antimicrob. Chemother. 8(Suppl. B):15-21.
2. Harper P. B. 1981. The in vitro properties of ceftazidime. J. Antimicrob. Chemother. 8(Suppl. B):5-13.
3. Antibacterial activity of ceftazidime (GR 20263) against routine hospital isolates and highly resistant strains of Enterobacteriaceac and Pseudomonas aeruginosa;Leigh D. A.;J. Antimicrob. Chemother. S(Suppl. B):107-110.,1981
4. Metzler C. M. 1979. NonLin a computer program for parameter estimation in nonlinear situations. Technical report 729217292/005. The Upjohn Co. K Mich.
5. Antibacterial activity and P-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa;Neu H. C.;Antimicrob. Agents Chemother.,1982
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献